Back to Search
MATTHEW CONNOR, MD
MD
Otolaryngology Physician
NPI: 1831412295IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
ME139236(FL)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2010
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Comparison of Clinical Profiles and Mortality Outcomes Between Influenza and COVID-19 Patients Invasively Ventilated in the ICU: A Retrospective Study From All Paris Public Hospitals From 2016 to 2021.
PMID 35923591·Crit Care Explor·2022
8-other
Mitigating the Impact of Emerging Animal Infectious Disease Threats: First Emerging Animal Infectious Diseases Conference (EAIDC) Report.
PMID 35632689·Viruses·2022
7-preclinical
Baloxavir vs oseltamivir: reduced utilization and costs in influenza.
PMID 35404552·Am J Manag Care·2022
8-other
Real-time alerting system for COVID-19 and other stress events using wearable data.
PMID 34845389·Nat Med·2022
8-other
Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset.
PMID 34586364·JAMA Netw Open·2021
8-other
Early detection of SARS-CoV-2 and other infections in solid organ transplant recipients and household members using wearable devices.
PMID 33735480·Transpl Int·2021
6-review
Epidemiology of laboratory-confirmed influenza among kidney transplant recipients compared to the general population-A nationwide cohort study.
PMID 33252189·Am J Transplant·2021
8-other
Efficacy of baloxavir marboxil on household transmission of influenza infection.
PMID 33014405·J Pharm Health Care Sci·2020
8-other
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
PMID 32640124·N Engl J Med·2020
4-observational
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
PMID 32526195·Lancet Infect Dis·2020
3-trial
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2).
PMID 32516282·Pediatr Infect Dis J·2020
3-trial
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.
PMID 31910344·Expert Rev Anti Infect Ther·2020
6-review
Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.
PMID 30684563·Antiviral Res·2019
3-trial
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
PMID 30316915·Antiviral Res·2018
8-other
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
PMID 30184455·N Engl J Med·2018
3-trial
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.
PMID 29635437·Clin Infect Dis·2018
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 8TH ST N
NAPLES, FL 34102 - Phone
- (239) 262-1171
Quick Facts
- NPI
- 1831412295
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile